Login
$KURA
$7.15 +$0.06 (0.85%) After hours

$KURA 8-K/A SEC Filings

Filed On Filing
18 Mar 2016 8-K/A: Financial Statements and Exhibits

LA JOLLA, Calif., March 17, 2016 – Kura Oncology, Inc., (NASDAQ: KURA) a clinical stage biopharmaceutical company, today announced highlights and financial results for the fourth quarter and full year ended December 31, 2015.

02 Jul 2015 8-K/A: Financial Statements and Exhibits

***Text Omitted and Filed Separately with the Securities and Exchange Commission.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support